Ben-Tzvi Avraham Insider Trades

Insider Trading History

Track insider trading activity for Ben-Tzvi Avraham. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Mainz Biomed N.V.
Mainz Biomed N.V. MYNZ
Director
Holding Value $500k 139,141 shares
Last Trade
May 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$96k 137,141 shares
$0.70
$3.59
Indaptus Therapeutics
Indaptus Therapeutics INDP
Director
Holding Value $119k 25,100 shares
Last Trade
Jan 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.3k 25,000 shares
$2.89
$4.75
Indaptus Therapeutics
Indaptus Therapeutics INDP
Director
Holding Value $119k 25,000 shares
Last Trade
Dec 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.8k 25,000 shares
$1.95
$4.75
Black Titan
Black Titan BTTC
Director
Holding Value $0 0 shares
Last Trade
Oct 01, 2025 Sale
No data
No data
$0.97
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10
Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 CYCCP
Director
Holding Value $3.54M 700,000 shares
Last Trade
Feb 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.22M 700,000 shares
$8.89
$5.05
Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals CYCC
Director
Holding Value $4.46M 700,000 shares
Last Trade
Feb 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.9M 700,000 shares
$77.04
$6.36
UBS AG London Branch - ZC SP ETN REDEEM 12/02/2026 USD 100
UBS AG London Branch - ZC SP ETN REDEEM 12/02/2026 USD 100 FIEE
Director
Holding Value $719k 159,364 shares
Last Trade
Sep 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.1M 159,364 shares
$201.23
$4.51
Minim
Minim MINM
Director
Holding Value $575k 159,364 shares
Last Trade
Sep 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$303k 159,364 shares
$1.90
$3.61
Opgen
Opgen OPGN
Director
Holding Value $2.39M 100,000 shares
Last Trade
Apr 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$710k 100,000 shares
$7.10
$23.91
UBS AG London Branch - ZC SP ETN REDEEM 12/02/2026 USD 100
UBS AG London Branch - ZC SP ETN REDEEM 12/02/2026 USD 100 FIEE
Director
Holding Value $113k 25,000 shares
Last Trade
Jan 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.03M 25,000 shares
$201.23
$4.51
Minim
Minim MINM
Director
Holding Value $90.3k 25,000 shares
Last Trade
Jan 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.3k 25,000 shares
$2.41
$3.61
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
Director
Holding Value $155k 66,250 shares
Last Trade
Oct 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$137k 16,250 shares
$8.44
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
Director
Holding Value $117k 50,000 shares
Last Trade
Jul 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$522k 50,000 shares
$10.44
$2.34
Titan Pharmaceuticals (de)
Titan Pharmaceuticals (de) TTNP
Director
Holding Value $234k 100,000 shares
Last Trade
Jun 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.63M 125,000 shares
$13.00
$2.34

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up